A Rare Presentation of COVID-19 with Pulmonary Embolism

Özgenur Günçkan1, Önder Öztürk1, Veysel Atilla Ayyıldız2

  • 1Department of Pulmonary Medicine, Faculty of Medicine, Süleyman Demirel University, Isparta - Turquia.

Insights

This case study highlights a patient with COVID-19 who developed pulmonary embolism and pleural effusions without lung opacities. It underscores the need for clinical awareness of concurrent conditions in COVID-19 patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Hematology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, can lead to severe complications like hypoxia, hyperinflammation, and coagulopathy.
  • Coagulopathy in COVID-19 is linked to thrombotic events, such as pulmonary embolism, but underlying mechanisms require further investigation.
  • The overlapping initial symptoms of COVID-19 and other conditions necessitate physician awareness for accurate diagnosis.

Observation:

  • A case is presented of a patient with COVID-19 infection.
  • The patient exhibited pulmonary embolism and pleural effusions.
  • Notably, the patient did not present with characteristic ground-glass opacities in the lungs.

Findings:

  • The case demonstrates a presentation of pulmonary embolism and pleural effusions in conjunction with COVID-19.
  • This occurred in the absence of typical lung findings like ground-glass opacities.
  • It suggests that COVID-19 can manifest with thrombotic and effusive complications even without clear radiographic signs of pneumonia.

Implications:

  • This case broadens the understanding of potential COVID-19 complications beyond typical respiratory symptoms.
  • It emphasizes the importance of considering thrombotic events and effusions in COVID-19 patients, irrespective of lung imaging findings.
  • Physicians should maintain a high index of suspicion for these complications and consider concurrent diagnoses in patients presenting with similar symptoms.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
109
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
60
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
657
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
430